How do you manage immunotherapy-induced myasthenia gravis?

My go-to algorithm is well-represented in the paper by Dr. @Dr. First Last et al.

• Zubair et al., PMID 36439604

NCCN "Management of Immunotherapy-Related Toxicities" has a useful 'cheat sheet' as a quick reference for the overnight call.